Answers are grounded in this paper and cite their sources.
Comparative analysis shows similar efficacy and tolerability of PD-1 inhibitors in very elderly patients with cutaneous squamous cell carcinoma, suggesting non-cancer mortality influences results.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Amir et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: